Objective: To report genealogic, clinical, imaging, neuropathologic, and genetic data from a Canadian kindred with dystonia and brain calcinosis originally described in 1985.

Methods: The authors performed clinical examinations and CT and PET studies of the head and analyzed blood samples. One autopsy was performed.

Results: The family tree was expanded to 166 individuals. No individuals were newly affected with dystonia, but postural tremor developed in two. The mean age at symptom onset was 19 years. Eight individuals had dystonia: three focal, one segmental, one multifocal, and three generalized. Seven displayed additional signs: chorea, intellectual decline, postural tremor, and dysarthria. CT studies were performed on five affected and 10 at-risk family members. All affected individuals and eight at-risk individuals had brain calcinosis. PET scans in two individuals showed reduced D(1)- and D(2)-receptor binding and reduced uptake of 6-[(18)F]fluoro-l-dopa. Autopsy of one affected individual showed extensive depositions of calcium in the basal ganglia, thalamus, cerebral white matter, and cerebellum. No specific immunohistochemistry abnormalities were seen. Genome search data showed no evidence of linkage to the previously described loci IBGC1, DYT1, and DYT12.

Conclusions: The phenotype of this family consists of dystonia-plus syndrome. Brain calcium deposits vary in severity and distribution, suggesting that calcifications alone are not entirely responsible for the observed clinical signs. Further studies are needed to elucidate the etiology of this heterogeneous group of disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000230141.40784.09DOI Listing

Publication Analysis

Top Keywords

brain calcinosis
8
postural tremor
8
individuals
6
autosomal dominant
4
dominant dystonia-plus
4
dystonia-plus cerebral
4
cerebral calcifications
4
calcifications objective
4
objective report
4
report genealogic
4

Similar Publications

This case highlights the surgical steps and nuances in preserving the pituitary stalk to ensure good endocrinological outcomes during endoscopic craniopharyngioma resection.

View Article and Find Full Text PDF

Medial intracranial carotid artery calcifications and hematoma expansion in deep intracerebral hemorrhage.

Ann Clin Transl Neurol

December 2024

Department of Continuity of Care and Frailty, Neurology Unit, ASST-Spedali Civili, Brescia, Italy.

Background: Medial intracranial carotid artery calcifications (ICAC) are associated with impaired vascular physiology, increased arterial stiffness and pulse pressure. Their presence might therefore be associated with increased risk of intracerebral hemorrhage (ICH) expansion, according to the avalanche model. We explored the association between ICAC presence and pattern and hematoma expansion (HE).

View Article and Find Full Text PDF

Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab.

Sci Rep

November 2024

Division of Neurosurgery, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, 36-1, Nishi-cho, Yonago, 683-8504, Tottori, Japan.

In this study, we focused on calcification and diffusion restriction, which sometimes appear around the resection cavity or periventricular white matter in patients with high-grade glioma (HGG) treated with bevacizumab (BVZ), as candidate imaging biomarkers for BVZ treatment efficacy. We investigated the timing of the appearance of diffusion restriction and calcification using magnetic resonance imaging and computed tomography in 35 patients with newly diagnosed or recurrent HGG treated with BVZ. In 17 (48.

View Article and Find Full Text PDF

Targeting TREM2 signaling shows limited impact on cerebrovascular calcification.

Life Sci Alliance

January 2025

Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland

Brain calcification, the ectopic mineral deposits of calcium phosphate, is a frequent radiological finding and a diagnostic criterion for primary familial brain calcification. We previously showed that microglia curtail the growth of small vessel calcification via the triggering receptor expressed in myeloid 2 (TREM2) in the mouse model of primary familial brain calcification. Because boosting TREM2 function using activating antibodies has been shown to be beneficial in other disease conditions by aiding in microglial clearance of diverse pathologies, we investigated whether administration of a TREM2-activating antibody could mitigate vascular calcification in mice.

View Article and Find Full Text PDF

Meta-analysis of deep learning approaches for automated coronary artery calcium scoring: Performance and clinical utility AI in CAC scoring: A meta-analysis: AI in CAC scoring: A meta-analysis.

Comput Biol Med

December 2024

Institute of Biophotonics, National Yang-Ming Chiao Tung University, 155, Sec. 2, Li-Nong St. Beitou Dist., Taipei, 112304, Taiwan; National Yang Ming Chiao Tung University, Brain Research Center, Taiwan; National Yang Ming Chiao Tung University, Medical Device Innovation and Translation Center, Taiwan. Electronic address:

Introduction: Manual Coronary Artery Calcium (CAC) scoring, crucial for assessing coronary artery disease risk, is time-consuming and variable. Deep learning, particularly through Convolutional Neural Networks (CNNs), promises to automate and enhance the accuracy of CAC scoring, which this study investigates.

Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive literature search across PubMed, Embase, Web of Science, and IEEE databases from their inception until November 1, 2023, and selected studies that employed deep learning for automated CAC scoring.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!